Press Release Capricor Therapeutics to Report Second Quarter 2026 Financial Results and Provide Recent Corporate Update on August 13 Aug 10
Press Release Capricor Therapeutics Provides Update on FDA Advisory Committee Meeting for Deramiocel Jul 30
Press Release The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy Jul 29